HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chinpaisal, C. Articles by Wei, L.-N. Search for Related Content PubMed PubMed Citation Articles by Chinpaisal, C. Articles by Wei, L.-N. Social Bookmarking                      What's this?

J Biol Chem, Vol. 273, Issue 29, 18077-18085, July 17, 1998

Mechanisms of the Mouse Orphan Nuclear Receptor TR2-11-mediated Gene Suppression

From the Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455

The mouse orphan nuclear receptor TR2-11 functions as a repressor for reporter genes containing a direct repeat-5 or direct repeat-4 hormone response element. The functional domains responsible for its suppressive activity are defined, including the DNA-binding domain and the ligand-binding domain. The C-terminal 30 amino acid residues can be deleted without compromising its suppressive activity, whereas a deletion for 40 amino acids completely abolishes the suppressive activity and receptor dimerization, and reduces the DNA-binding affinity. Point mutation at three conserved leucine residues located on the predicted dimer interface abolishes the suppressive activity, receptor dimerization and its DNA binding property. However, mutation at two consecutive glutamate residues located within the hinge between the last two helices of the ligand-binding domain (helix 10 and helix 11 according to the human retinoid receptor X  structure) drastically reduces its DNA-binding affinity and abrogates the suppressive activity without compromising its ability to dimerize, indicating that receptor dimerization property can be functionally uncoupled from its suppressive activity. A transferable, active silencing activity is encoded within the DEF segment of the receptor molecule, as evidenced by the suppression of a GAL4 reporter by a chimeric protein containing the DNA-binding domain of GAL4 and the DEF segment of TR2-11. Moreover, the C-terminal 49 amino acid sequence is required for this trans-suppressive activity. It is suggested that TR2-11 functions as a repressor, mediated by mechanisms requiring high affinity DNA binding, receptor dimerization, and active silencing.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				M. D. M. Huq, N.-P. Tsai, S. A. Khan, and L.-N. Wei Lysine Trimethylation of Retinoic Acid Receptor-{alpha}: A Novel Means To Regulate Receptor Function Mol. Cell. Proteomics, April 1, 2007; 6(4): 677 - 688. [Abstract] [Full Text] [PDF]

				K. D. Baker, R. B. Beckstead, D. J. Mangelsdorf, and C. S. Thummel Functional interactions between the Moses corepressor and DHR78 nuclear receptor regulate growth in Drosophila Genes & Dev., February 15, 2007; 21(4): 450 - 464. [Abstract] [Full Text] [PDF]

				E. Moran and G. Jimenez The tailless nuclear receptor acts as a dedicated repressor in the early Drosophila embryo. Mol. Cell. Biol., May 1, 2006; 26(9): 3446 - 3454. [Abstract] [Full Text] [PDF]

				P. J. Franco, M. Farooqui, E. Seto, and L.-N. Wei The Orphan Nuclear Receptor TR2 Interacts Directly with Both Class I and Class II Histone Deacetylases Mol. Endocrinol., August 1, 2001; 15(8): 1318 - 1328. [Abstract] [Full Text] [PDF]

				H.-J. Im, D. Smirnov, T. Yuhi, S. Raghavan, J. E. Olsson, G. E. Muscat, P. Koopman, and H. H. Loh Transcriptional Modulation of Mouse {micro}-Opioid Receptor Distal Promoter Activity by Sox18 Mol. Pharmacol., June 1, 2001; 59(6): 1486 - 1496. [Abstract] [Full Text]

				L.-N. Wei, X. Hu, and C. Chinpaisal Constitutive Activation of Retinoic Acid Receptor beta 2 Promoter by Orphan Nuclear Receptor TR2 J. Biol. Chem., April 14, 2000; 275(16): 11907 - 11914. [Abstract] [Full Text] [PDF]

				C.-H. Lee and L.-N. Wei Characterization of Receptor-interacting Protein 140 in Retinoid Receptor Activities J. Biol. Chem., October 29, 1999; 274(44): 31320 - 31326. [Abstract] [Full Text] [PDF]

				V. Giguère Orphan Nuclear Receptors: From Gene to Function Endocr. Rev., October 1, 1999; 20(5): 689 - 725. [Abstract] [Full Text]

				C.-H. Lee, C. Chinpaisal, and L.-N. Wei Cloning and Characterization of Mouse RIP140, a Corepressor for Nuclear Orphan Receptor TR2 Mol. Cell. Biol., November 1, 1998; 18(11): 6745 - 6755. [Abstract] [Full Text]

				C.-H. Lee, C. Chinpaisal, and L.-N. Wei A Novel Nuclear Receptor Heterodimerization Pathway Mediated by Orphan Receptors TR2 and TR4 J. Biol. Chem., September 25, 1998; 273(39): 25209 - 25215. [Abstract] [Full Text] [PDF]

				X. Hu, J. Bi, H. H. Loh, and L.-N. Wei An Intronic Ikaros-binding Element Mediates Retinoic Acid Suppression of the Kappa Opioid Receptor Gene, Accompanied by Histone Deacetylation on the Promoters J. Biol. Chem., February 9, 2001; 276(7): 4597 - 4603. [Abstract] [Full Text] [PDF]